Skip to main content
. 2018 Dec 3;11:8633–8642. doi: 10.2147/OTT.S186186

Figure 4.

Figure 4

Pectolinarigenin inhibited PI3K/AKT/mTOR/ERK signaling pathway.

Notes: Pectolinarigenin treatment markedly inhibited PI3K/AKT/mTOR/ERK signaling protein levels in SMMC7721 and PLC5 cell lines for 48 hours. *P<0.05 vs. the indicated group.